There is increasing evidence that both EPA and DHA support insulin regulation and reduce the risk of developing T2DM
Glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and islet amyloid polypeptide (amylin) are all incretins
Many phase II and III trials and different retrospective studies are showing the improvement data in patients with cardiovascular risk factors and outcomes
The role of glucagon on type 2 diabetes at a glance
Available from: Linda Gigliotti 1 , Hope Warshaw 2 , Alison Evert 3 , Colleen Dawkins 4 , Julie Schwartz 5 , Caroline Susie 6 , Robert Kushner 7 , Savitha Subramanian 8 , Deepa Handu 9 , Mary Rozga 10 Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care
Glucagon-Like Peptide 1 Modulates Calcium Responses to Glutamate and Membrane Depolarization in Hippocampal Neurons